Physical Agent-Based Treatments for Overactive Bladder: A Review
Open Access
- 31 August 2022
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (17) , 5150
Abstract
Almost one-fifth of the people in the world experience a decrease in quality of life due to overactive bladder (OAB) syndrome. The main bothersome symptoms are urgency accompanied by urinary frequency and nocturia. This chronic, disabling condition is first managed by reducing fluid intake and pelvic floor muscle training, supplemented with antimuscarinic drugs, if necessary. However, refractory cases often still occur. In more severe cases, invasive surgical interventions can be considered; yet, the success rate is still inconsistent, and there is a high complication rate. This condition is frustrating for patients and challenging for the medical staff involved. Although its pathophysiology has not been fully elucidated, peripheral autonomic somatic and sensory afferent receptors are considered to be involved in this condition. Hence, currently, physical agent-based treatments such as neuromodulation have taken a significant place in the third-line therapy of OAB. The efficacy and safety profiles of electrical and magnetic stimulation continue to evolve. Physical-based agents provide an appealing option owing to their effectiveness and minimal side effects. In addition, more physical therapies using light and shock energy are currently being investigated. Thus, a comprehensive understanding of these modalities is an extremely important aspect to provide the most suitable modalities for patients.Keywords
Funding Information
- Ministry of Science and Technology (110-2314-B-038-001, 110-2811-E-038-500-MY3, 110-2314-B-305-001, 109-2314-B-305-001, 109-2221-E-305-001-MY2, 109-2221-E-038-005-MY3, 109-2314-B-038-132, USTP-NTUT-TMU-111-03, DP2-111-21121-01-N-03-04)
- University System of Taipei Joint Research Program (110-2314-B-038-001, 110-2811-E-038-500-MY3, 110-2314-B-305-001, 109-2314-B-305-001, 109-2221-E-305-001-MY2, 109-2221-E-038-005-MY3, 109-2314-B-038-132, USTP-NTUT-TMU-111-03, DP2-111-21121-01-N-03-04)
- Higher Education Sprout Project (110-2314-B-038-001, 110-2811-E-038-500-MY3, 110-2314-B-305-001, 109-2314-B-305-001, 109-2221-E-305-001-MY2, 109-2221-E-038-005-MY3, 109-2314-B-038-132, USTP-NTUT-TMU-111-03, DP2-111-21121-01-N-03-04)
This publication has 86 references indexed in Scilit:
- Percutaneous Tibial Nerve Stimulation for the Long-Term Treatment of Overactive Bladder: 3-Year Results of the STEP StudyJournal of Urology, 2013
- Randomized, double‐blind, sham‐controlled evaluation of the effect of functional continuous magnetic stimulation in patients with urgency incontinenceNeurourology and Urodynamics, 2007
- Sacral Neuromodulation in Women With Idiopathic Detrusor Overactivity Incontinence: Decreased Overactivity but Unchanged Bladder Contraction Strength and Urethral Resistance During VoidingJournal of Urology, 2006
- Extracorporeal pelvic floor magnetic stimulation in children with voiding dysfunctionBJU International, 2005
- Magnetic Stimulation of the Sacral Roots for the Treatment of Urinary Frequency and Urge Incontinence: An Investigational Study and Placebo Controlled TrialJournal of Urology, 2002
- POSTERIOR TIBIAL NERVE STIMULATION AS NEUROMODULATIVE TREATMENT OF LOWER URINARY TRACT DYSFUNCTIONJournal of Urology, 2001
- POSTERIOR TIBIAL NERVE STIMULATION AS NEUROMODULATIVE TREATMENT OF LOWER URINARY TRACT DYSFUNCTIONJournal of Urology, 2001
- EFFECT OF FUNCTIONAL CONTINUOUS MAGNETIC STIMULATION FOR URINARY INCONTINENCEJournal of Urology, 2000
- A URODYNAMIC STUDY OF SURFACE NEUROMODULATION VERSUS SHAM IN DETRUSOR INSTABILITY AND SENSORY URGENCYJournal of Urology, 1998
- A URODYNAMIC STUDY OF SURFACE NEUROMODULATION VERSUS SHAM IN DETRUSOR INSTABILITY AND SENSORY URGENCYJournal of Urology, 1998